Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056964 · ClinicalTrials.gov registry record
HEART Pathway Implementation
A clinical trial of Acute Coronary Syndrome and Chest Pain, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 14,717
- Enrollment target
- 1
- Study location
NCT02056964 is a study of Acute Coronary Syndrome and Chest Pain that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 14,717 participants, above the 2,354-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (525% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02056964, a study of Acute Coronary Syndrome and Chest Pain, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 14,717 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of the HEART Pathway, a clinical decision aid for the care of patients with chest pain, in a "real-world" clinical setting. This will be accomplished through the building of a transformative collaboration between research, education, and health systems operations to more effectively and efficiently provide patient care.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,717 participants |
| Start Date | 2013-11 |
| Est. Completion | 2019-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056964
The ClinicalTrials.gov registry entry for NCT02056964 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14,717 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,354-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (525% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02056964 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02056964 about?
NCT02056964 is a clinical study titled "HEART Pathway Implementation". The purpose of this study is to determine the effectiveness of the HEART Pathway, a clinical decision aid for the care of patients with chest pain, in a "real-world" clinical setting. This will be accomplished through the building of a transformative collaboration between research, education, and he...
What is the current status of trial NCT02056964?
This trial is currently completed. The enrollment target is 14,717 participants. The study started on 2013-11. Estimated completion is 2019-01-31.
What conditions does trial NCT02056964 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Chest Pain, Chest Pain Atypical Syndrome, Chest Pain Rule Out Myocardial Infarction.
Who is sponsoring clinical trial NCT02056964?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02056964 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.